ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy—phase II investigator-initiated trial (NCCH2412/MK015)
- DOI
- 10.1016/j.esmogo.2026.100322
- Published
- 2026-06
- Container
- ESMO Gastrointestinal Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmogo.2026.100322,
title = {ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy—phase II investigator-initiated trial (NCCH2412/MK015)},
author = {H. Fujii and H. Hirano and T. Kudo and K. Tsuchihashi and H. Shoji and N. Okita and T. Hirose and A. Takashima and M. Yokoyama and M. Kawasaki and Y. Shuda and M. Naito and K. Ichikawa and K. Sekine and J. Sato and N. Yamamoto and K. Kato},
year = {2026},
journal = {ESMO Gastrointestinal Oncology},
doi = {10.1016/j.esmogo.2026.100322},
url = {https://doi.org/10.1016/j.esmogo.2026.100322}
}RIS
TY - JOUR TI - ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy—phase II investigator-initiated trial (NCCH2412/MK015) AU - H. Fujii AU - H. Hirano AU - T. Kudo AU - K. Tsuchihashi AU - H. Shoji AU - N. Okita AU - T. Hirose AU - A. Takashima AU - M. Yokoyama AU - M. Kawasaki AU - Y. Shuda AU - M. Naito AU - K. Ichikawa AU - K. Sekine AU - J. Sato AU - N. Yamamoto AU - K. Kato PY - 2026 JO - ESMO Gastrointestinal Oncology DO - 10.1016/j.esmogo.2026.100322 UR - https://doi.org/10.1016/j.esmogo.2026.100322 ER -
APA
Fujii, H., Hirano, H., Kudo, T., Tsuchihashi, K., Shoji, H., Okita, N., Hirose, T., Takashima, A., Yokoyama, M., Kawasaki, M., Shuda, Y., Naito, M., Ichikawa, K., Sekine, K., Sato, J., Yamamoto, N., & Kato, K. (2026). ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy—phase II investigator-initiated trial (NCCH2412/MK015). ESMO Gastrointestinal Oncology. https://doi.org/10.1016/j.esmogo.2026.100322
Source records
- crossref · retrieved 2026-09-26T02:43:09.575Z